Pérez-López Faustino R, Calvo-Latorre Julia, Alonso-Ventura Vanesa, Bueno-Notivol Juan, Martínez-Domínguez Samuel J, Chedraui Peter
Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain; Department of Obstetrics and Gynecology, Lozano-Blesa University Hospital, Zaragoza, Spain.
Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain.
Pregnancy Hypertens. 2018 Oct;14:213-221. doi: 10.1016/j.preghy.2018.01.003. Epub 2018 Jan 3.
To investigate the association between endometriosis and preeclampsia and/or its severe forms (eclampsia and/or the hemolysis, elevated liver enzymes and low platelet count [HELLP] syndrome) in pregnancies conceived either spontaneously or by assisted reproductive technology (ART).
Systematic review and meta-analysis of observational studies. Search in PubMed-Medline, Scopus, Web of Science, Cochrane Library, Clinicaltrials.gov, the UK Clinical Trials Gateway, and the Australian New Zealand Clinical Trials Registry was conducted from inception through 21 June 2017, without language restrictions. Primary outcome was preeclampsia and/or its severe forms (eclampsia and/or HELLP syndrome) in pregnant women. Random-effects models were used for meta-analyses. Endometriosis effect was estimated as odds ratio (OR) with 95% confidence interval (CI).
A total of 9 cohort and 4 case-control studies were eligible for data analysis, including 39,816 pregnancies with endometriosis and 2,831,065 without. Women with endometriosis diagnosed through biopsy did not have a higher preeclampsia, eclampsia and HELLP syndrome risk as compared to those without (OR 1.01, 95% CI 0.56-1.82); this was found the same even if endometriosis was diagnosed using other procedures (OR 1.15, 95% CI 0.94-1.40). Preeclampsia, eclampsia and HELLP syndrome risk was also not increased in women with endometriosis conceiving spontaneously (OR 1.21; 95% CI 0.94-1.56) or through ART (OR 0.74; 95% CI 0.41-1.35).
This meta-analysis evidences that endometriosis was not associated to a higher risk of preeclampsia and/or its severe forms in pregnancies either conceived spontaneously or through ART.
探讨子宫内膜异位症与自然受孕或通过辅助生殖技术(ART)受孕的孕妇子痫前期和/或其严重形式(子痫和/或溶血、肝酶升高和血小板减少[HELLP]综合征)之间的关联。
对观察性研究进行系统评价和荟萃分析。从创刊至2017年6月21日,在PubMed-Medline、Scopus、Web of Science、Cochrane图书馆、Clinicaltrials.gov、英国临床试验网关和澳大利亚新西兰临床试验注册中心进行检索,无语言限制。主要结局是孕妇子痫前期和/或其严重形式(子痫和/或HELLP综合征)。荟萃分析采用随机效应模型。子宫内膜异位症效应估计为比值比(OR)及95%置信区间(CI)。
共有9项队列研究和4项病例对照研究符合数据分析条件,包括39816例患有子宫内膜异位症的妊娠和2831065例未患子宫内膜异位症的妊娠。经活检诊断为子宫内膜异位症的女性与未患子宫内膜异位症的女性相比,子痫前期、子痫和HELLP综合征风险并无升高(OR 1.01,95%CI 0.56-1.82);即使采用其他方法诊断子宫内膜异位症,结果也是如此(OR 1.15,95%CI 0.94-1.40)。自然受孕(OR 1.21;95%CI 0.94-1.56)或通过ART受孕(OR 0.74;95%CI 0.41-1.35)的子宫内膜异位症女性,子痫前期、子痫和HELLP综合征风险也未增加。
这项荟萃分析表明,子宫内膜异位症与自然受孕或通过ART受孕的孕妇发生子痫前期和/或其严重形式的较高风险无关。